# US 2006/0154354 A1 · High yield pertussis vaccine production strain and method for making same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154354 A1
- Document ID: US20060154354A1
- Status: Published application
- Kind: A1
- Application number: 10/312,272
- Filed: 2001-06-26
- Published: 2006-07-13
- Earliest claimed: 2000-06-26
- Assignees: The United States of America as represented by the Department of Health and Human Services
- Inventors: Tod Merkel; Jerry Keith; Xiaoming Yang
- Web page: https://patentgrep.com/patent/US20060154354A1

## CPC

- C12N 1/20: Bacteria; Culture media therefor
- C07K 14/235: from Bordetella (G)
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides a vaccine production strain of Bordetella bronchiseptica that produces a pertussis toxin in high yield. The present invention provides a method for creating a Bordetella bronchiseptica cell line which produces a Bordetella pertussis toxin comprising the steps of introducing a plasmid containing a DNA encoding antibiotic resistance into a Bordetella bronchiseptica strain, selecting for isolates in which the DNA encoding antibiotic resistance is recombinantly incorporated into the chromosome in place of the Bordetella bronchiseptica toxin gene, introducing a plasmid containing DNA encoding subunits of the Bordetella pertussis toxins into the Bordetella bronchiseptica isolates; and, selecting for isolates in which DNA encoding Bordetella pertussis toxin subunit is recombinantly incorporated into the chromosome, the resulting cells producing the Bordetella pertussis toxin. The present invention further provides a method for creating a Bordetella bronchiseptica cell line which produces a Bordetella pertussis toxin and does not express filamentous hemagglutinin.

## Claims

### Claim 1

A bvg-positive Bordetella bronchiseptica strain wherein DNA encoding Bordetella bronchiseptica toxin is replaced by DNA encoding subunits S1 through S5 of the Bordetella pertussis toxin and wherein the Bordetella bronchiseptica DNA encoding filamentous hemagglutinin is removed or rendered non-functional, whereby the strain does not express filamentous hemagglutinin.

### Claim at position 2

2-22. (canceled)

### Claim 23 (depends on 1)

The Bordetella bronchiseptica strain of claim 1, wherein the strain is TY 178 having the ATCC patent deposit designation PTA-2111.
